Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas

BACKGROUND: Soft-tissue sarcomas are a rare group of malignant tumors that usually are treated with surgical excision and radiation therapy, but recently, pazopanib, an oral tyrosine kinase inhibitor, has been used in patients with metastases who do not respond to standard chemotherapy regimens. Bas...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Orthop Relat Res
Glavni autori: Suehara, Yoshiyuki, Kohsaka, Shinji, Yamaguchi, Shigeo, Hayashi, Takuo, Kurihara, Taisei, Sano, Kei, Sasa, Keita, Akaike, Keisuke, Ueno, Toshihide, Kojima, Shinya, Ikegami, Masachika, Mizuno, Sho, Okubo, Taketo, Kim, Youngji, Kaneko, Kazuo, Saito, Tsuyoshi, Kato, Shunsuke, Mano, Hiroyuki
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer 2020
Teme:
Selected Proceedings of the 2019 International Society of Limb Salvage Annual Meeting (Guest Editor: John H. Healey, Md)
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594915/
https://ncbi.nlm.nih.gov/pubmed/32567826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CORR.0000000000001322
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items